I completed my residency training at Geisinger Medical Center in Danville, PA in a combined residency for both internal medicine and pediatrics where I was also Chief Resident. I then completed my specialty training in hematology and oncology at UF where I was also Chief Fellow. I chose to specialize in hematology and oncology due to the evolving landscape of immunotherapy and the need to improve care for the adolescent and young adult (AYA) population. I specialize in treating sarcomas - a rare cancer that affects the bones and soft tissues. As Director of the AYA Cancer Program, I work closely with our colleagues in Pediatric Oncology to optimize care for our AYA patients aged 15-45.
I aim to cure cancer using novel immunotherapies. As I believe we are close to this goal, I aim to decrease the morbidity and mortality of surgical interventions for cancer by developing therapies to work together with immunotherapy for advanced disease. We research various nanoparticles to accomplish this goal in my lab.
Outside of work, I enjoy spending time with my wife and our 7 children serving in church, playing board games, sports, and movie nights!
This phase II trial compares the effect of immunotherapy with ipilimumab and nivolumab alone to their combination with cabozantinib in treating patients with soft tissue sarcoma that has spread from where it first started to nearby tissue, lymph鈥�
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesA trained biomedical engineer, Leighton Elliott, MD, was 11 hours away on a mission trip in Vietnam helping to fit patients with prosthetic legs when he鈥�
